Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 54-60

  Erickson, Kirsten ^a   Patterson, Ruth E ^a   Flatt, Shirley W ^a   Natarajan, Loki ^a   Parker, Barbara A ^a   Heath, Dennis D ^a   Laughlin, Gail A ^a   Saquib, Nazmus ^a   Rock, Cheryl L ^a   Pierce, John P ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHRONIC HYPERGLYCEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; EDUCATIONAL STATUS; ETHNICITY; EVENT FREE SURVIVAL; FEMALE; GLYCEMIC CONTROL; HEART DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINURIA; HUMANS; MIDDLE AGED; PROGNOSIS;

EID: 79951991748     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.3183     Document Type: Article

References (38)

1. Yancik R, Wesley MN, Ries LA, et al: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892, 2001 (Pubitemid 32171549)
2. Srokowski TP, Fang S, Hortobagyi GN, et al: Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170-2176, 2009
3. Tammemagi CM, Nerenz D, Neslund-Dudas C, et al: Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294:1765-1772, 2005 (Pubitemid 41434622)
4. Cowie CC, Rust KF, Ford ES, et al: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32:287-294, 2009
5. Harris MI, Klein R, Welborn TA, et al: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819, 1992
6. Barone BB, Yeh HC, Snyder CF, et al: Longterm all-cause mortality in cancer patients with preexisting diabetes mellitus: A systematic review and meta-analysis. JAMA 300:2754-2764, 2008
7. Reference deleted
8. Jee SH, Ohrr H, Sull JW, et al: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194-202, 2005 (Pubitemid 40095870)
9. Lipscombe LL, Goodwin PJ, Zinman B, et al: The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389-395, 2008 (Pubitemid 351644852)
10. Zhou XH, Qiao Q, Zethelius B, et al: Diabetes, prediabetes and cancer mortality. Diabetologia 53:1867-1876, 2010
11. Giordano SH, Jiralerspong S, Lopez A, et al: Diabetes, obesity and survival in a large cohort of early-stage breast cancer patients. J Clin Oncol 28:154s, 2010 (suppl 15S; abstr 1503)
12. Patterson RE, Flatt SW, Saquib N, et al: Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859-865, 2010
13. Giovannucci E, Harlan DM, Archer MC, et al: Diabetes and cancer: A consensus report. CA Cancer J Clin 60:207-221, 2010
14. Gillett MJ: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334, 2009
15. Buell C, Kermah D, Davidson MB: Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 30:2233-2235, 2007
16. Endocrine Society: The Endocrine Society statement on the use of A1C for diabetes diagnosis and risk estimation. http://www.endo-society.org/ advocacy/upload/TES-Statement-on-A1C-Use.pdf
17. Pierce JP, Natarajan L, Caan BJ, et al: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289-298, 2007 (Pubitemid 47080483)
18. Pierce JP, Faerber S, Wright FA, et al: A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: The Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials 23:728-756, 2002 (Pubitemid 36005481)
19. Saquib N, Pierce JP, Saquib J: Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology [epub ahead of print on March 31, 2010]
20. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
21. Johnson-Kozlow M, Rock CL, Gilpin EA, et al: Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer. Am J Health Behav 31:193-202, 2007
22. Hong S, Bardwell WA, Natarajan L, et al: Correlates of physical activity level in breast cancer survivors participating in the Women's Healthy Eating and Living (WHEL) Study. Breast Cancer Res Treat 101:225-232, 2007 (Pubitemid 46115429)
23. Belfiore A, Frittitta L, Costantino A, et al: Insulin receptors in breast cancer. Ann N Y Acad Sci 784:173-188, 1996 (Pubitemid 26194762)
24. Mathieu MC, Clark GM, Allred DC, et al: Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians 109:565-571, 1997 (Pubitemid 27495695)
25. Papa V, Belfiore A: Insulin receptors in breast cancer: Biological and clinical role. J Endocrinol Invest 19:324-333, 1996 (Pubitemid 126450113)
26. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002 (Pubitemid 34032594)
27. Borugian MJ, Sheps SB, Kim-Sing C, et al: Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963-968, 2003 (Pubitemid 37413395)
28. Pasanisi P, Berrino F, De Petris M, et al: Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236-238, 2006
29. Tabaei BP, Herman WH, Jabarin AF, et al: Does diabetes care compete with the provision of women's preventive care services? Diabetes Care 28:2644-2649, 2005
30. Beckman TJ, Cuddihy RM, Scheitel SM, et al: Screening mammogram utilization in women with diabetes. Diabetes Care 24:2049-2053, 2001 (Pubitemid 33716519)
31. Yancik R, Ries LG, Yates JW: Breast cancer in aging women: A population-based study of contrasts in stage, surgery, and survival. Cancer 63:976-981, 1989 (Pubitemid 19063212)
32. Satariano WA: Comorbidity and functional status in older women with breast cancer: Implications for screening, treatment, and prognosis. J Gerontol 47:24-31, 1992
33. Newschaffer CJ, Penberthy L, Desch CE, et al: The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med 156:85-90, 1996 (Pubitemid 26011595)
34. Bergman L, Dekker G, van Kerkhoff EH, et al: Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat 18:189-198, 1991
35. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994 (Pubitemid 24027550)
36. West DW, Satariano WA, Ragland DR, et al: Comorbidity and breast cancer survival: A comparison between black and white women. Ann Epidemiol 6:413-419, 1996 (Pubitemid 26372529)
37. Louwman WJ, Janssen-Heijnen ML, Houterman S, et al: Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based study. Eur J Cancer 41:779-785, 2005 (Pubitemid 40347298)
38. Fleming ST, Pursley HG, Newman B, et al: Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 43:132-140, 2005 (Pubitemid 40222631)